Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 19, Issue 1, Pages -
Publisher
Informa UK Limited
Online
2023-02-22
DOI
10.1080/21645515.2023.2178791
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation
- (2022) Shi-Suo Du et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hallmarks of Cancer: New Dimensions
- (2022) Douglas Hanahan Cancer Discovery
- Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC)
- (2022) Inna M. Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer
- (2022) Zhan Shi et al. Frontiers in Oncology
- Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial
- (2022) Kim A Reiss et al. LANCET ONCOLOGY
- Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
- (2021) Jiali Yu et al. NATURE MEDICINE
- Understanding and treating the inflammatory adverse events of cancer immunotherapy
- (2021) Michael Dougan et al. CELL
- Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
- (2021) Cristina Valero et al. Nature Communications
- Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors
- (2021) Jessica J. Waninger et al. JAMA Network Open
- The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectives
- (2021) Jamal Majidpoor et al. CLINICAL IMMUNOLOGY
- Inflammatory Markers Predict Survival in Patients With Advanced Gastric and Colorectal Cancers Receiving Anti–PD-1 Therapy
- (2021) Xiaona Fan et al. Frontiers in Cell and Developmental Biology
- Estimated Projection of US Cancer Incidence and Death to 2040
- (2021) Lola Rahib et al. JAMA Network Open
- Pancreatic Cancer
- (2021) Wungki Park et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial
- (2021) Xiaofei Zhu et al. LANCET ONCOLOGY
- Targeting the IGF-axis potentiates immunotherapy for pancreatic ductal adenocarcinoma liver metastases by altering the immunosuppressive microenvironment.
- (2021) Masakazu Hashimoto et al. MOLECULAR CANCER THERAPEUTICS
- The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
- (2021) Lars Ny et al. Nature Communications
- Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort
- (2021) G. Fornarini et al. ESMO Open
- Radiotherapy and immunotherapy for cancer: From "systemic" to "multi-site"
- (2020) Ainhoa Arina et al. CLINICAL CANCER RESEARCH
- Lactate dehydrogenase: a marker of diminished antitumor immunity
- (2020) Sandra Van Wilpe et al. OncoImmunology
- Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors
- (2020) Lihong Peng et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications
- (2020) Claudio Luchini et al. GUT
- Lymphocyte‐monocyte ratio (LMR) can predict bendamustine therapeutic efficacy in low‐grade B‐cell lymphoma
- (2020) Joji Shimono et al. International Journal of Laboratory Hematology
- BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
- (2020) Bruno Bockorny et al. NATURE MEDICINE
- Challenges and Opportunities for Pancreatic Cancer Immunotherapy
- (2020) Adham S. Bear et al. CANCER CELL
- Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
- (2020) Aurélien Marabelle et al. LANCET ONCOLOGY
- Inflammation and Cancer: Triggers, Mechanisms, and Consequences
- (2019) Florian R. Greten et al. IMMUNITY
- Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- (2019) Eileen M. O’Reilly et al. JAMA Oncology
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Aurelien Marabelle et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
- (2019) Maria Esperanza Rodriguez-Ruiz et al. NATURE IMMUNOLOGY
- Colorectal cancer liver metastases – a population-based study on incidence, management and survival
- (2018) Jennie Engstrand et al. BMC CANCER
- Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer
- (2018) Laura Mezquita et al. JAMA Oncology
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen
- (2014) A. B. Sharabi et al. Cancer Immunology Research
- Tumor-Associated Neutrophils: New Targets for Cancer Therapy
- (2011) A. D. Gregory et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now